These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9762665)

  • 21. Active immunization with proteolipid protein (190-209) induces ascending paralysing experimental autoimmune encephalomyelitis in C3H/HeJ mice.
    Göbel K; Bittner S; Ruck T; Budde T; Wischmeyer E; Döring F; Wiendl H; Meuth SG
    J Immunol Methods; 2011 Mar; 367(1-2):27-32. PubMed ID: 21199659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N; Mendel I; Ben-Nun A
    Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic interventions targeting CD40L (CD154) and CD40: the opportunities and challenges.
    Law CL; Grewal IS
    Adv Exp Med Biol; 2009; 647():8-36. PubMed ID: 19760064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD40/CD40L interaction is essential for the induction of EAE in the absence of CD28-mediated co-stimulation.
    Girvin AM; Dal Canto MC; Miller SD
    J Autoimmun; 2002 Mar; 18(2):83-94. PubMed ID: 11908941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
    J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expansion by self antigen is necessary for the induction of experimental autoimmune encephalomyelitis by T cells primed with a cross-reactive environmental antigen.
    Carrizosa AM; Nicholson LB; Farzan M; Southwood S; Sette A; Sobel RA; Kuchroo VK
    J Immunol; 1998 Oct; 161(7):3307-14. PubMed ID: 9759846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of atherosclerosis in mice by inhibition of CD40 signalling.
    Mach F; Schönbeck U; Sukhova GK; Atkinson E; Libby P
    Nature; 1998 Jul; 394(6689):200-3. PubMed ID: 9671306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD40 expression on graft infiltrates and parenchymal CD154 (CD40L) induction in human chronic renal allograft rejection.
    Gaweco AS; Mitchell BL; Lucas BA; McClatchey KD; Van Thiel DH
    Kidney Int; 1999 Apr; 55(4):1543-52. PubMed ID: 10201021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockade of the CD154-CD40 costimulatory pathway prevents the development of experimental autoimmune glomerulonephritis.
    Reynolds J; Khan SB; Allen AR; Benjamin CD; Pusey CD
    Kidney Int; 2004 Oct; 66(4):1444-52. PubMed ID: 15458437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B cells play a cooperative role via CD40L-CD40 interaction in T cell-mediated experimental autoimmune neuritis in Lewis rats.
    Zhu W; Mix E; Jin T; Adem A; Zhu J
    Neurobiol Dis; 2007 Mar; 25(3):642-8. PubMed ID: 17188497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Four different synthetic peptides of proteolipid protein induce a distinct antibody response in MP4-induced experimental autoimmune encephalomyelitis.
    Recks MS; Grether NB; van der Broeck F; Ganscher A; Wagner N; Henke E; Ergün S; Schroeter M; Kuerten S
    Clin Immunol; 2015 Jul; 159(1):93-106. PubMed ID: 25959684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-CD40L accelerates renal disease and adenopathy in MRL-lpr mice in parallel with decreased thymocyte apoptosis.
    Russell JQ; Mooney T; Cohen PL; MacPherson B; Noelle RJ; Budd RC
    J Immunol; 1998 Jul; 161(2):729-39. PubMed ID: 9670949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional and in situ evidence for nitric oxide production driven by CD40-CD40L interactions in graft-versus-leukemia reactivity.
    Müerköster S; Laman JD; Rocha M; Umansky V; Schirrmacher V
    Clin Cancer Res; 2000 May; 6(5):1988-96. PubMed ID: 10815924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo.
    Niimi M; Pearson TC; Larsen CP; Alexander DZ; Hollenbaugh D; Aruffo A; Linsley PS; Thomas E; Campbell K; Fanslow WC; Geha RS; Morris PJ; Wood KJ
    J Immunol; 1998 Nov; 161(10):5331-7. PubMed ID: 9820506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
    Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cell and antibody responses in remitting-relapsing experimental autoimmune encephalomyelitis in (C57BL/6 x SJL) F1 mice.
    Zhang GX; Yu S; Gran B; Li J; Calida D; Ventura E; Chen X; Rostami A
    J Neuroimmunol; 2004 Mar; 148(1-2):1-10. PubMed ID: 14975581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy targeting the CD40/CD154 costimulatory pathway for treatment of autoimmune disease.
    Howard LM; Miller SD
    Autoimmunity; 2004 Aug; 37(5):411-8. PubMed ID: 15621565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice.
    Balasa B; Krahl T; Patstone G; Lee J; Tisch R; McDevitt HO; Sarvetnick N
    J Immunol; 1997 Nov; 159(9):4620-7. PubMed ID: 9379064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration.
    Kataoka H; Sugahara K; Shimano K; Teshima K; Koyama M; Fukunari A; Chiba K
    Cell Mol Immunol; 2005 Dec; 2(6):439-48. PubMed ID: 16426494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis.
    Suvannavejh GC; Dal Canto MC; Matis LA; Miller SD
    J Clin Invest; 2000 Jan; 105(2):223-31. PubMed ID: 10642601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.